Results 11 to 20 of about 33,475 (169)

Dobutamine-sparing versus dobutamine-to-all strategy in cardiac surgery:a randomized noninferiority trial [PDF]

open access: yes, 2021
BackgroundThe detrimental effects of inotropes are well-known, and in many fields they are only used within a goal-directed therapy approach. Nevertheless, standard management in many centers includes administering inotropes to all patients undergoing ...
de Albuquerque Piccioni, Marilde   +50 more
core   +2 more sources

Factors associated with cardiovascular events after simultaneous liver–kidney transplant from the US Multicenter Simultaneous Liver–Kidney Transplant Consortium

open access: yesHepatology Communications, EarlyView., 2022
Abstract Cardiovascular disease is a leading complication after both liver and kidney transplantation. Factors associated with and rates of cardiovascular events (CVEs) after simultaneous liver–kidney transplant (SLKT) are unknown. This was a retrospective cohort study of adult SLKT recipients between 2002 and 2017 at six centers in six United Network ...
Jennifer Jo   +19 more
wiley   +1 more source

Clinical pharmacology of dobutamine and dopamine in preterm neonates [PDF]

open access: yes, 2014
Dobutamine is a β1 selective stimulant. β Receptor agonists are used to stimulate the rate and the force of cardiac contraction. The chronotropic effect is useful for the treatment of arrhythmias whereas the inotropic effect is useful to augment the ...
Pacifici,Gian Maria
core   +2 more sources

The effects on arterial haemoglobin oxygen saturation and on shunt of increasing cardiac output with dopamine or dobutamine during one-lung ventilation [PDF]

open access: yes, 2004
Publisher's copy made available with the permission of the publisher © Australian Society of AnaesthetistsTheoretically, if the cardiac output were increased in the presence of a given intrapulmonary shunt, the arterial saturation should improve as the ...
Russell, W.   +3 more
core   +1 more source

DOBUTAMINE USAGE IN CARDIOLOGICAL PRACTICE [PDF]

open access: yes, 2016
Dobutamine is inotropic drug indicated in systolic dysfunction. Data on dobutamine pharmacology, its effects on hemodynamics, coronary and peripheral blood flow, myocardial electrophysiology are presented. Clinical usage and the main contraindications of
M. Yu. Giljarov
core   +1 more source

Correlating Pulmonary Hemodynamics With HP <sup>129</sup>Xe Dissolved-Phase MRSI in a Controlled Porcine Intervention Study. [PDF]

open access: yesMagn Reson Med
ABSTRACT Purpose Pulmonary hypertension is related to a 1‐year mortality ranging from < 5% to > 20% in low‐ and high‐risk groups. Right heart catheterization is the diagnostic gold standard, associated with a 1.1% rate of severe adverse events, posing the need for a non‐invasive diagnostic tool.
Andersen MP   +7 more
europepmc   +2 more sources

Additional file 1 of The effect of dobutamine in sepsis: a propensity score matched analysis

open access: yes, 2021
Additional file 1: Figure S1. Distribution of propensity scores between treatment group (Dobutamine group) and control group (Non-dobutamine group) before and after match. Figure S2.
Xiaoling Ye (6036959)   +4 more
core   +1 more source

Levosimendan Plus Dobutamine in Acute Decompensated Heart Failure Refractory to Dobutamine

open access: yes, 2020
Randomized studies showed that Dobutamine and Levosimendan have similar impact on outcome but their combination has never been assessed in acute decompensated heart failure (ADHF) with low cardiac output. This is a retrospective, single-center study that
Camille Deguillard   +17 more
core   +1 more source

Outcome Predictors and Safety of Home Dobutamine Intravenous Infusion in End Stage Heart Failure Patients

open access: yes, 2021
International audiencePatients in end-stage heart failure can experiment cardiogenic shock and may not be weanable from dobutamine. The fate of these patients is a challenge for doctors, patients, family, and the institution.
Antoine Jobbé-Duval   +21 more
core   +1 more source

Dobutamine-Induced Myoclonus in a Peritoneal Dialysis Patient: Case Report

open access: yes, 2023
Dobutamine is a weak beta-1 and a potent beta-2 adrenergic agonist commonly used to treat patients in cardiogenic shock. It enhances myocardial contractibility, increasing cardiac output.
Lee, Jean   +6 more
core   +2 more sources

Home - About - Disclaimer - Privacy